Non-interventional Surveillance of Effectiveness of Symbicort® Maintenance And Reliever Therapy (Symbicort® SMART) in the Treatment of Moderate and Severe Asthma

N/ACompletedNCT00573222

AstraZeneca330 enrolled

Overview

This is a 3-month non-interventional, observational study on patients with moderate and severe asthma.

Study Type

OBSERVATIONAL

Enrollment

330

Conditions

Asthma

Interventions

SymbicortDRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with moderate and severe asthma on Symbicort SMART treatment Exclusion Criteria: * Under 18 years old

Locations (13)

Research Site

Čakovec, Croatia

Research Site

Dubrovnik, Croatia

Research Site

Osijek, Croatia

Research Site

Požega, Croatia

Outcomes

Primary Outcomes

To evaluate & describe asthma control in adult patients w/moderate to severe asthma treated w/Symbicort SMART following the frequency, type & severity of symptoms through the Asthma Control Questionnaire.

Secondary Outcomes

to evaluate the safety of Symbicort SMART treatment through the number and type of reported adverse events 2. assessment of patient's satisfaction with the treatment 3.assessment of physician's satisfaction with the treatment

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.